# Fluorescence Imaging With Indocyanine Green(ICG) in Endoscopic Spinal Surgery

> **NCT05808140** · PHASE1,PHASE2 · COMPLETED · sponsor: **Zhongnan Hospital** · enrollment: 40 (actual)

## Conditions studied

- Disc Herniation

## Interventions

- **DRUG:** Indocyanine Green
- **DEVICE:** Fluorescence imaging

## Key facts

- **NCT ID:** NCT05808140
- **Lead sponsor:** Zhongnan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-11
- **Primary completion:** 2025-12-14
- **Final completion:** 2025-12-14
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05808140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05808140, "Fluorescence Imaging With Indocyanine Green(ICG) in Endoscopic Spinal Surgery". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT05808140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*